Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sinus variability: value of rhythmology].

J Y Le Heuzey1

  • 1Service de cardiologie A, hôpital Broussais, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Editorial].

Presse medicale (Paris, France : 1983)·2016
Same author

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Antithrombotic treatment of atrial fibrillation: new insights.

Thrombosis research·2012
Same author

[The implantable defibrillator in France: from EVADEF to CeRtiTuDe].

Archives des maladies du coeur et des vaisseaux·2007
Same author

[Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide].

Annales de cardiologie et d'angeiologie·2006
Same author

[Clinical evolution of patients following investigation of atrial vulnerability after a first cerebral ischaemic accident].

Archives des maladies du coeur et des vaisseaux·2006
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Heart rate variability (HRV) analysis assesses autonomic nervous system influence on the heart. Decreased HRV after myocardial infarction signals a poor prognosis, offering a reliable risk factor.

Area of Science:

  • Cardiology
  • Autonomic Neuroscience

Context:

  • Heart rate variability (HRV) quantifies autonomic nervous system (ANS) modulation of cardiac function.
  • HRV analysis utilizes temporal and spectral methods over varying durations.
  • Specific ANS components influencing HRV parameters can be identified.

Purpose:

  • To explore the diagnostic and prognostic utility of HRV in cardiovascular conditions.
  • To investigate the role of ANS in cardiac health and disease.
  • To highlight emerging applications of HRV in clinical practice.

Summary:

  • Reduced HRV post-myocardial infarction is a significant indicator of poor prognosis.
  • Decreased HRV is also noted in heart failure, though its clinical significance is under investigation.
  • HRV analysis provides insights into ANS function in various cardiovascular and non-cardiac pathologies.

Related Experiment Videos

Impact:

  • HRV serves as a reliable prognostic factor in post-myocardial infarction patients.
  • Potential for HRV in evaluating cardiovascular interventions and managing non-cardiac conditions with ANS involvement.
  • Ongoing research promises significant advancements in HRV applications.